![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Mako Surgical Corp. (MM) | NASDAQ:MAKO | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 29.99 | 0 | 01:00:00 |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): February 13, 2009
MAKO Surgical Corp.
(Exact name of registrant as specified in its charter)
Delaware |
001-33966 |
20-1901148 |
(State or other jurisdiction of
|
(Commission File Number) |
(I.R.S. Employer Identification No.) |
2555 Davie Road
Ft. Lauderdale, Florida 33317
(Address of principal executive offices and zip code)
Registrants telephone number, including area code: (954) 927-2044
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
(e) The Compensation Committee (the Committee ) of the Board of Directors of MAKO Surgical Corp. (the Company ) approved by unanimous written consent, effective February 13, 2009, the Companys 2009 Leadership Cash Bonus Plan (the 2009 Leadership Bonus Plan ) and the 2009 Performance Bonus Plan for the benefit of Steven J. Nunes, the Companys Senior Vice President of Sales and Marketing (hereinafter, the 2009 Nunes Bonus Plan ).
The 2009 Leadership Bonus Plan will be used for the purpose of allocating annual performance bonuses to the Companys management-level employees, including its executive officers, for the plan year ending December 31, 2009. Under the 2009 Leadership Bonus Plan, based on the individual participants performance and level of responsibility within the Company, cash bonuses will be awarded by converting the weighted point system used to determine the Companys attainment of the following ten quarterly and annual goals set forth on the Companys 2009 Metrics Scorecard (the Scorecard ) into a percentage that is applied to the participants base salary.
|
|
Financial Goals: |
|
o |
Commercial launch of the MAKO RIO robotic arm, interactive, orthopedic system (the RIO System ), including target revenue and target average material cost of goods sold |
|
o |
Commercial launch of the Company-branded RESTORIS® family of knee implant systems, including a target number of MAKOplasty® procedures, target revenue, material cost of goods sold and monthly utilization per customer site |
|
o |
Achievement of budget |
|
o |
Development of plan for targeted cost reductions |
|
|
Customer Focus Goals: |
|
o |
Implementing and conducting external customer satisfaction surveys with achievement of target results and attaining target MAKOplasty® procedure success rate |
|
o |
Implementing and conducting internal customer satisfaction surveys and attaining target rapid response on-time delivery goals |
|
o |
Achieving target quality and reliability relating to the RIO System |
|
|
Building for the Future: |
|
o |
Attaining targets with respect to expanded applications of the RIO System |
|
o |
Achieving certain targets with respect to adoption of MAKOplasty®: submitting manuscripts to peer-reviewed journals and abstracts to orthopedic conferences and completing white papers; patient follow-up; and economic value follow-up |
|
o |
Developing and maintaining the Companys strategic plan |
Pursuant to the 2009 Nunes Bonus Plan, Mr. Nunes will be eligible for a bonus based on the Companys achievement of certain quarterly and annual sales-related performance goals set forth on the Scorecard. Under the 2009 Nunes Bonus Plan, the determination as to whether Mr. Nunes will be eligible to receive a cash bonus and/or a grant of 40,000 incentive stock options to purchase shares of the Companys common stock will be based on a point system derived from weighting the sales-related performance goals set forth on the Scorecard.
2
Any bonus award distributed to Mr. Nunes under the 2009 Nunes Bonus Plan will be in addition to any cash bonus that Mr. Nunes will be eligible to earn under the 2009 Leadership Bonus Plan.
The foregoing description of the terms and conditions of the 2009 Leadership Bonus Plan and the 2009 Nunes Bonus Plan is qualified in its entirety by reference to the copies of the bonus plans attached as Exhibits 10.1 and 10.2, respectively, to this Form 8-K and incorporated herein by this reference.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
Exhibit No. |
|
Description of Exhibit |
10.1 |
|
MAKO Surgical Corp. 2009 Leadership Cash Bonus Plan |
10.2 |
|
2009 Performance Bonus Plan for S. Nunes - SVP of Sales & Marketing |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
|
MAKO Surgical Corp. |
|
|
|
|
|
|
|
By: |
|
|
|
|
Menashe R. Frank,
|
3
1 Year Mako Surgical Corp. (MM) Chart |
1 Month Mako Surgical Corp. (MM) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions